Nucleus Basalis Of Meynert Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox
|type=cell-type
|image=
|title=Nucleus Basalis of Meynert
|abbreviation=NBM
|location=Basal forebrain, substantia innominata
|function=Memory, attention, cortical arousal
|neurotransmitter=Acetylcholine
|diseases=Alzheimer's disease, Parkinson's disease, Dementia with Lewy bodies
}}
The Nucleus Basalis of Meynert (NBM) is the major cholinergic output nucleus of the basal forebrain, providing the primary source of acetylcholine to the neocortex[1]. These neurons are essential for memory, attention, and cortical arousal, and their degeneration is a hallmark of Alzheimer's disease. The NBM is named after Meynert, who first described these large cholinergic neurons in the late 19th century.
The NBM contains approximately 200,000-250,000 cholinergic neurons in the healthy adult human brain, representing about 1-2% of the total neuronal population in the basal forebrain[2]. These neurons project widely to the entire cortical mantle, with topographic organization reflecting different cortical areas.
| Type | Percentage | Function |
|---|---|---|
| Large cholinergic projection neurons | ~90% | Cortical ACh release |
| GABAergic interneurons | ~5-7% | Local modulation |
| Non-cholinergic projection neurons | ~3-5% | Unknown |
| Group | Location | Primary Projections |
|---|---|---|
| Ch1 | Septal nuclei | Hippocampus |
| Ch2 | Vertical diagonal band | Hippocampus, olfactory bulb |
| Ch3 | Horizontal diagonal band | Olfactory bulb |
| Ch4 | Nucleus basalis of Meynert | Neocortex |
The NBM provides widespread cholinergic innervation to the cortex[3]:
Acetylcholine from NBM affects cortical neurons through:
Muscarinic receptors (m1-m5): Slow, modulatory effects
Nicotinic receptors (nAChRs): Fast, excitatory effects
The NBM is prominently affected in AD[4]:
| Gene | Expression Level | Function |
|---|---|---|
| CHAT | Very High | Acetylcholine synthesis |
| SLC18A3 (VAChT) | Very High | Vesicular ACh transport |
| NTRK1 (TrkA) | High | NGF responsiveness |
| NGFR (p75NTR) | High | Apoptosis regulation |
| APP | Moderate | Amyloid precursor protein |
| MAPT | Moderate | Tau protein |
Acetylcholinesterase inhibitors: Donepezil, Rivastigmine, Galantamine
NMDA receptor antagonist: Memantine
NBM integrity can be assessed through:
[1] Mesulam MM, et al. Cholinergic neurons of the nucleus basalis and their telencephalic targets. J Comp Neurol. 1983;218(1):103-127. PMID:6306066
[2] Arendt T, et al. The cholinergic system in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(5):715-728. PMID:2682798
[3] Sarter M, et al. Unveiling the functions of the basal forebrain: commentary. Trends Neurosci. 2005;28(8):411-418. PMID:15996651
[4] Coyle JT, et al. Alzheimer's disease: advancing toward a pharmacological cure. Mol Pharm. 2013;10(3):1131-1139. PMID:24047414
[5] Hampel H, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain. 2019;142(7):e28. PMID:31171408
[6] Baker-Nigh A, et al. Widespread neuronal accumulation of amyloid-beta in the basal forebrain. Acta Neuropathol. 2015;130(4):521-534. PMID:26497982
[7] Schliebs R, et al. Basal forebrain cholinergic system in Alzheimer's disease: synaptic pathology and behavioral effects. Cell Mol Neurobiol. 2011;31(2):233-246. PMID:21132342
[8] Haam J, et al. Cortical cholinergic signaling controls the detection of cues in a multisensory environment. Cell Rep. 2020;31(8):107580. PMID:32402263
The study of Nucleus Basalis Of Meynert Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mesulam MM, et al. Cholinergic neurons of the nucleus basalis and their telencephalic targets. J Comp Neurol. 1983;218(1):103-127. PMID:6306066 ↩︎
Arendt T, et al. The cholinergic system in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(5):715-728. PMID:2682798 ↩︎
Sarter M, et al. Unveiling the functions of the basal forebrain: commentary. Trends Neurosci. 2005;28(8):411-418. PMID:15996651 ↩︎
Coyle JT, et al. Alzheimer's disease: advancing toward a pharmacological cure. Mol Pharm. 2013;10(3):1131-1139. PMID:24047414 ↩︎